跳到正文
专业监测临床试验状态

临床试验状态

查看登记总量、状态变化与来源证据。

查看全球线索 ↓

全球总体情况

ClinicalTrials.gov(美国登记平台)· 药物及生物制品干预性试验

不代表全球所有登记平台的全部试验

全球范围

全球登记总数

223,846

较昨日净变化:+64

统计日期:2026-11-10(北京时间)

采集时间:2026/11/10 05:16:18

对比快照:2026/11/9 05:15:57

重点关注 · 试验状态 (净变化与昨日快照比较)

暂停

706

净变化:0

今日发现线索:0 条

提前终止

20,280

净变化:+2

今日发现线索:2 条

撤回

8,136

净变化:+2

今日发现线索:2 条
其他状态 (净变化与昨日快照比较)

在研 / 筹备

39,503

净变化:+44

已完成

127,076

净变化:+30

状态未知

28,145

净变化:-14

其他

0

净变化:0

统计口径与采集状态 · 线索最近采集:2026/11/10 13:17:28

每项试验按登记号计一次,不代表全球所有登记平台的全部试验。净变化是两次快照的总量之差;今日线索按系统发现日期统计,包含历史回溯,不受下方筛选影响,列表还可能包含暂停后恢复。

ClinicalTrials.gov 最近成功采集:2026/11/10 13:17:28。

逐项基线:2026/11/3 09:25:29 建立,共 223,520 项;此前变化不保证完整。

筛选监测范围

按试验地点、发现时间和状态查询

全球 · 新增异常及后续变化

按发现时间统计,含历史回溯;不等于上方快照期间的新增事件。

导出当前异常 CSV
今日 4 条 · 昨日 0 条

匹配 53 条线索(暂停后恢复 4 条 · 暂停 3 条 · 提前终止 33 条 · 撤回 13 条),不代表全部新增事件。

试验提前终止状态未知 → 提前终止

High-Dose Ambroxol in GBA1-Related Parkinson

NCT06193421 · 申办者:Agyany Pharma LTD试验地点:Israel

登记停止说明(原文):Sponsor's decision

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验提前终止尚未招募 → 提前终止

A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects

NCT07818330 · 申办者:Teikoku Pharma USA, Inc.试验地点:澳大利亚

登记停止说明(原文):Sponsor decision, after observation of adverse events

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回

Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy

NCT07185945 · 申办者:Guru Sonpavde试验地点:未提供

登记停止说明(原文):Funder withdrew

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

NCT05504187 · 申办者:Kira Pharmacenticals (US), LLC.试验地点:未提供

登记停止说明(原文):Sponsor Decision - terminated due to changes in company priorities and not related to safety concerns

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-09发现时间:2026/11/10 01:15:50推送接口已接受
试验提前终止状态未知 → 提前终止

Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis

NCT04008316 · 申办者:Assistance Publique - Hôpitaux de Paris试验地点:法国

登记停止说明(原文):Sponser decision

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回招募中 → 入组前撤回

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

NCT04563520 · 申办者:Emory University试验地点:美国

登记停止说明(原文):The study was withdrawn because the pharmaceutical sponsor withdrew support for the study. No participants were enrolled before termination.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止进行中(不再招募) → 提前终止

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

NCT06006143 · 申办者:Yale University试验地点:美国

登记停止说明(原文):recruitment challenges

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回

Phenobarbital for Agitated Delirium

NCT07548489 · 申办者:Duke University试验地点:美国

登记停止说明(原文):Not approved by IRB

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
暂停后恢复暂停 → 招募中

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

NCT06922604 · 申办者:City of Hope Medical Center试验地点:美国
来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验暂停招募中 → 暂停

Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

NCT04318717 · 申办者:Washington University School of Medicine试验地点:美国

登记停止说明(原文):protocol amendment

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回尚未招募 → 入组前撤回

Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp

NCT07803562 · 申办者:University of California, San Diego试验地点:美国

登记停止说明(原文):Lack of funding

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回暂停 → 入组前撤回

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)

NCT06378528 · 申办者:University of Wisconsin, Madison试验地点:未提供

登记停止说明(原文):Budgeting/funding

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止进行中(不再招募) → 提前终止

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

NCT05132075 · 申办者:Novartis Pharmaceuticals
试验地点:美国、Argentina、澳大利亚等 25 个国家或地区

美国、Argentina、澳大利亚、加拿大、中国、Finland、Greece、Hong Kong、Hungary、Iceland、印度、意大利、Jordan、黎巴嫩、Malaysia、Mexico、Portugal、Romania、Slovenia、South Korea、西班牙、Taiwan、Thailand、Turkey (Türkiye)、Vietnam

登记停止说明(原文):Business reasons and not based on any safety concerns.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止招募中 → 提前终止

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05723107 · 申办者:NYU Langone Health试验地点:美国

登记停止说明(原文):Halted prematurely

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验入组前撤回状态未知 → 入组前撤回

Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults

NCT03435718 · 申办者:Oxfendazole Development Group试验地点:未提供

登记停止说明(原文):Study cancelled prior to initiation as the Oxfendazole Development Group is collaborating on a similar study being conducted by AB Prisma, NCT4713787

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-06发现时间:2026/11/7 01:17:52推送接口已接受
试验提前终止暂停 → 提前终止

Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine

NCT04981860 · 申办者:University of Miami试验地点:美国

登记停止说明(原文):The study was terminated early due to operational feasibility challenges, including multi-site coordination and administrative barriers. The study team determined continuation was not feasible, and all study activities were discontinued.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止状态未知 → 提前终止

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

NCT04648202 · 申办者:invoX Pharma Limited试验地点:美国、西班牙

登记停止说明(原文):The study was terminated early due to a strategic business decision by the Sponsor, unrelated to safety.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止招募中 → 提前终止

CT-95 in Advanced Cancers Associated With Mesothelin Expression

NCT06756035 · 申办者:Context Therapeutics Inc.试验地点:美国

登记停止说明(原文):The study was halted prematurely and will not resume; participants are no longer receiving intervention or undergoing evaluations. The termination was not due to any safety or efficacy concerns.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止招募中 → 提前终止

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

NCT05603104 · 申办者:Dr. Inge Winter试验地点:Israel

登记停止说明(原文):The site in Israel stopped recruitment due to logistic reasons. Other sites are recruiting for 2023-506602-39-00, 2023-506605-19-00, 2023-506617-21-00.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
试验提前终止暂停 → 提前终止

Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

NCT03756389 · 申办者:BioMimetix JV, LLC试验地点:美国

登记停止说明(原文):Re-formulation of study product needed.

来源:ClinicalTrials.gov(美国登记平台)来源更新:2026-11-05发现时间:2026/11/6 01:16:30推送接口已接受
第 1 页下一页

试验暂停不等于 FDA Clinical Hold。英文内容保留官方原文。